XML 56 R46.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Subsequent Events (Details) - Subsequent Event |  | 1 Months Ended
--- | --- | ---
May 06, 2024 | Apr. 30, 2024 USD ($) kg
Treated patients within clinical trial | Median |  |
Subsequent Event |  |
Survival period for participants in clinical trial | 13 months |
Patients within placebo group of clinical trial | Median |  |
Subsequent Event |  |
Survival period for participants in clinical trial | 12 months 9 days |
Raw materials |  |
Subsequent Event |  |
Minimum amount to purchase raw materials |  | $ 3,768,000
Minimum kilograms required to purchase | kg |  | 120
Non-refundable advance to vendor |  | $ 1,130,400

X
- Definition Amount of the non-refundable advance to vendor. + References No definition available. + Details
Name: | glyc_NonRefundableAdvanceToVendor
Namespace Prefix: | glyc_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The projected overall monthly survival period in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | glyc_ProjectedOverallMonthlySurvival
Namespace Prefix: | glyc_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition The minimum amount the entity agreed to spend under the long-term purchase commitment. + References No definition available. + Details
Name: | us-gaap_LongTermPurchaseCommitmentAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Mass of goods that must be purchased within the specified time period of the agreement to avoid penalties or unfavorable effects on pricing, among other adverse consequences. + References No definition available. + Details
Name: | us-gaap_LongTermPurchaseCommitmentMinimumMassRequired
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:massItemType
Balance Type: | na
Period Type: | duration

X
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481674/830-30-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 855 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2 + Details
Name: | us-gaap_SubsequentEventLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementScenarioAxis=glyc_TreatedPatientsGroupMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MedianMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementScenarioAxis=glyc_NonTreatedPatientsGroupMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_InventoriesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |